Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

21.96 

0.18 0.9%

as of Jun 02 '23

52 Week Range:

2.02 21.98


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Probiotec Limited engages in the development, manufacture, packing, and sale of pharmaceuticals, consumer health, and fast-moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, ointments, and suspensions; powders and powder blending; and sprays, as well as manufactures and packages finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. The company was incorporated in 1996 and is headquartered in Laverton North, Australia.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Equity (BVPS) 1.20
1.19
1.22
0.72
0.79
0.82
0.78
0.90
0.79
0.84
growth rate -0.8% 2.5% -41.0% 9.7% 3.8% -4.9% 15.4% -12.2% 6.3%
Earnings BIT 2.24
2.00
-2.39
0.53
3.58
4.33
3.96
6.02
10.83
11.02
19.55
growth rate -10.7% -100.0% 100.0% 573.8% 20.8% -8.5% 52.3% 79.7% 1.8% 77.4%
Avg.PE 6.29
10.06
15.29
12.65
7.23
166.97
30.98
8.97
10.63
10.63
39.63
growth rate 59.9% 52.0% -17.3% -42.9% 2,209.4% -81.5% -71.1% 18.5% 0.0% 272.8%
ROA 1.20
0.57
0.84
-27.88
5.65
3.23
4.34
11.33
2.92
2.66
growth rate -52.5% 47.4% -100.0% 100.0% -42.8% 34.4% 161.1% -74.2% -8.9%
ROE 2.02
0.95
1.41
-47.60
9.64
5.13
7.38
22.18
6.35
7.51
growth rate -53.0% 48.4% -100.0% 100.0% -46.8% 43.9% 200.5% -71.4% 18.3%
ROIC 3.54
2.40
2.17
-34.66
8.56
5.00
6.83
17.37
5.77
5.34
growth rate -32.2% -9.6% -100.0% 100.0% -41.6% 36.6% 154.3% -66.8% -7.5%
Cur. Ratio 0.71
0.64
0.75
0.89
1.07
1.33
1.79
2.45
1.80
1.53
growth rate -9.9% 17.2% 18.7% 20.2% 24.3% 34.6% 36.9% -26.5% -15.0%
Quick Ratio 0.26
0.29
0.35
0.35
0.53
0.69
0.77
1.44
1.14
1.19
growth rate 11.5% 20.7% 0.0% 51.4% 30.2% 11.6% 87.0% -20.8% 4.4%
Leverage 1.62
1.73
1.62
1.84
1.59
1.60
1.79
2.13
2.22
3.36
growth rate 6.8% -6.4% 13.6% -13.6% 0.6% 11.9% 19.0% 4.2% 51.4%
Balance Sheet Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Acct.Receivable 8.00
11.00
9.65
8.34
8.70
10.82
16.47
18.76
22.94
24.45
31.23
growth rate 37.5% -12.3% -13.6% 4.3% 24.5% 52.2% 13.9% 22.3% 6.6% 27.7%
Acct.Payable 8.00
9.00
11.30
8.27
7.28
8.45
10.94
9.38
14.32
13.20
20.55
growth rate 12.5% 25.5% -26.8% -11.9% 16.0% 29.4% -14.2% 52.6% -7.8% 55.6%
Cur.Assets 23.00
25.00
22.57
21.66
18.61
21.37
42.63
47.07
46.19
67.78
74.63
growth rate 8.7% -9.7% -4.0% -14.1% 14.8% 99.5% 10.4% -1.9% 46.7% 10.1%
Total Assets 101.00
110.00
104.49
73.01
69.17
71.12
93.66
106.37
134.06
230.88
237.91
growth rate 8.9% -5.0% -30.1% -5.3% 2.8% 31.7% 13.6% 26.0% 72.2% 3.1%
Cash 0.20
1.00
1.12
0.12
0.51
0.32
1.82
8.84
6.31
28.43
22.20
growth rate 400.0% 11.7% -89.2% 320.3% -36.4% 464.7% 387.0% -28.7% 350.8% -21.9%
Inventory 14.00
13.00
11.68
9.88
9.12
9.75
11.56
13.25
15.70
13.90
19.60
growth rate -7.1% -10.1% -15.4% -7.7% 7.0% 18.5% 14.7% 18.5% -11.4% 41.0%
Cur.Liabilities 33.00
38.00
30.15
24.26
17.41
16.08
23.88
19.18
25.65
44.43
51.43
growth rate 15.2% -20.7% -19.5% -28.2% -7.6% 48.5% -19.7% 33.8% 73.2% 15.8%
Liabilities 39.00
46.00
40.17
33.38
25.54
26.55
41.31
56.52
73.55
162.26
158.86
growth rate 18.0% -12.7% -16.9% -23.5% 4.0% 55.6% 36.8% 30.1% 120.6% -2.1%
LT Debt 2.00
1.00
1.00
1.00
1.00
2.40
7.54
3.23
9.66
48.42
46.96
growth rate -50.0% 0.0% 0.0% 0.0% 140.0% 214.2% -57.2% 199.2% 401.2% -3.0%
Equity 62.50
63.50
64.32
39.63
43.63
44.57
52.35
49.85
60.51
68.61
79.05
growth rate 1.6% 1.3% -38.4% 10.1% 2.1% 17.5% -4.8% 21.4% 13.4% 15.2%
Common Shares 53.00
53.00
53.00
53.00
53.00
53.00
38.60
33.61
43.74
50.69
51.29
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% -27.2% -12.9% 30.1% 15.9% 1.2%
Cash Flow Statement Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Capital Expenditures 4.00
8.00
2.60
1.80
2.59
2.51
4.60
11.30
1.99
2.92
4.87
growth rate 100.0% -67.4% -30.8% 43.9% -3.2% 83.1% 145.7% -82.4% 46.6% 66.8%
Cash Dividends 0.00
0.00
1.06
1.06
1.06
1.06
1.25
1.88
2.99
3.77
3.98
growth rate 0.0% 0.0% 0.0% 18.1% 50.0% 59.5% 25.9% 5.7%
Cash From OA 4.00
5.00
5.31
2.32
5.04
4.09
6.22
-4.39
10.17
24.37
19.52
growth rate 25.0% 6.1% -56.2% 116.9% -18.9% 52.2% -100.0% 100.0% 139.5% -19.9%
FCF per Share -0.02
-0.08
-0.07
-0.01
-0.02
0.03
0.07
-0.20
-0.01
0.09
growth rate 0.0% 0.0% 0.0% 0.0% 100.0% 133.3% -100.0% 0.0% 100.0%
FCF -3.00
-4.00
1.00
-3.00
1.00
1.00
1.00
-17.00
5.00
20.00
14.66
growth rate 0.0% 100.0% -100.0% 100.0% 0.0% 0.0% -100.0% 100.0% 300.0% -26.7%
Income Statement Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Sales 66.00
67.00
68.21
63.31
65.61
60.65
66.44
73.24
107.22
120.51
182.33
growth rate 1.5% 1.8% -7.2% 3.6% -7.6% 9.5% 10.2% 46.4% 12.4% 51.3%
Op.Income 2.00
2.00
-2.39
0.53
3.58
4.33
3.96
6.02
10.83
11.02
19.55
growth rate 0.0% -100.0% 100.0% 573.8% 20.8% -8.5% 52.3% 79.7% 1.8% 77.4%
IBT 2.20
1.50
0.75
-0.52
3.09
3.99
4.00
4.52
8.90
7.72
18.04
growth rate -31.8% -50.1% -100.0% 100.0% 29.1% 0.3% 13.0% 96.8% -13.2% 133.6%
Net Income 2.00
1.00
0.90
-24.74
4.01
2.26
3.58
11.33
3.51
4.85
13.71
growth rate -50.0% -9.6% -100.0% 100.0% -43.6% 58.0% 216.8% -69.1% 38.2% 182.9%
EPS 0.02
0.01
0.02
-0.47
0.07
0.04
0.06
0.17
0.05
0.06
growth rate -50.0% 100.0% -100.0% 100.0% -42.9% 50.0% 183.3% -70.6% 20.0%
Gross Profit 29.00
29.00
24.80
23.40
23.98
22.79
22.85
22.68
31.78
38.70
57.24
growth rate 0.0% -14.5% -5.7% 2.5% -5.0% 0.3% -0.8% 40.2% 21.8% 47.9%
R&D 2.20
2.10
growth rate -4.6%

Quarterly Statements

Item Name Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Earnings BIT 3.89
4.18
4.18
5.60
5.60
growth rate 7.3% 0.0% 33.9% 0.0%
Balance Sheet Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Acct.Receivable 24.45
23.89
23.89
31.23
31.23
growth rate -2.3% 0.0% 30.7% 0.0%
Acct.Payable 13.20
22.95
22.95
20.55
20.55
growth rate 73.8% 0.0% -10.5% 0.0%
Cur.Assets 67.78
68.77
68.77
74.63
74.63
growth rate 1.5% 0.0% 8.5% 0.0%
Total Assets 230.88
219.03
219.03
237.91
237.91
growth rate -5.1% 0.0% 8.6% 0.0%
Cash 28.43
28.94
28.94
22.20
22.20
growth rate 1.8% 0.0% -23.3% 0.0%
Inventory 13.90
14.52
14.52
19.60
19.60
growth rate 4.4% 0.0% 35.0% 0.0%
Cur.Liabilities 44.43
49.30
49.30
51.43
51.43
growth rate 11.0% 0.0% 4.3% 0.0%
Liabilities 162.26
148.27
148.27
158.86
158.86
growth rate -8.6% 0.0% 7.2% 0.0%
LT Debt 48.42
48.09
48.09
46.96
46.96
growth rate -0.7% 0.0% -2.4% 0.0%
Equity 68.61
70.76
70.76
79.05
79.05
growth rate 3.1% 0.0% 11.7% 0.0%
Common Shares 50.69
50.69
50.69
51.29
51.29
growth rate 0.0% 0.0% 1.2% 0.0%
Cash Flow Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Capital Expenditures 0.98
0.98
0.98
1.45
1.45
growth rate 0.0% 0.0% 48.4% 0.0%
Cash Dividends 1.18
1.18
1.18
0.82
0.82
growth rate 0.0% 0.0% -30.6% 0.0%
Cash From OA 6.00
6.00
6.00
3.76
3.76
growth rate 0.0% 0.0% -37.2% 0.0%
FCF 5.02
5.02
5.02
2.31
2.31
growth rate 0.0% 0.0% -53.9% 0.0%
Income Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Sales 38.96
42.58
42.58
48.58
48.58
growth rate 9.3% 0.0% 14.1% 0.0%
Op.Income 4.18
4.18
4.18
5.60
5.60
growth rate 0.0% 0.0% 33.9% 0.0%
IBT 3.14
3.14
3.14
5.88
5.88
growth rate 0.0% 0.0% 87.3% 0.0%
Net Income 1.80
2.22
2.22
4.63
4.63
growth rate 23.1% 0.0% 108.5% 0.0%
Gross Profit 11.58
13.31
13.31
15.31
15.31
growth rate 15.0% 0.0% 15.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (68.64)

YOY Growth Grade:

E (32.38)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 40.93 406.67 12.28
EPS / Growth 18.1% 0.05 -68.7%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 9.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 9.6% 9.6%
Future PE 2.00 24.15 24.15
Future EPS 0.06 0.14 0.14
Value Price
MOS %
0.03
-99.9%
0.81
-96.3%
0.81
-96.3%
MOS Price 0.01 0.40 0.40
IRT 99.00 39.21 39.21

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.